PARAMETERS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH DIFFERENT DEGREES OF COMPENSATION OF INSULIN RESISTANCE
- Authors: Zhuravleva Y.1, Turyanskaya Y.2, Sokolova L.2, Gusev E.1
-
Affiliations:
- Institute of Immunology and Physiology of UB RAS, Yekaterinburg, Russian Federation
- Ural State Medical University Yekaterinburg, Russian Federation
- Section: Immunological readings in Chelyabinsk
- Submitted: 05.03.2025
- Accepted: 31.05.2025
- URL: https://rusimmun.ru/jour/article/view/17108
- DOI: https://doi.org/10.46235/1028-7221-17108-POC
- ID: 17108
Cite item
Full Text
Abstract
Abstract
The paper presents an analysis of systemic inflammatory markers in patients with insulin resistance leading to chronic metabolic disorders of various compensation degrees (decompensated and compensated type 2 diabetes mellitus - DM2, prediabetes). The aim: to analyse the features of chronic systemic inflammation marker production in patients with different stages of insulin resistance: prediabetes, compensated DM2 and decompensated DM2. Materials and Methods. The study included patients with hyperglycemia, who were divided into 3 groups according to blood glucose and glycated hemoglobin levels: 26 patients with prediabetes, 34 patients with compensated DM2 and 29 patients with decompensated DM2. The control group included healthy blood donors (n=89). Serum concentrations of C-reactive protein (CRP), interleukins (IL)-6, -8, -10, tumor necrosis factor alpha (TNFα), D-dimer, troponin I, myoglobin, cortisol, and procalcitonin were determined by enzyme immunoassay. The results of the study showed that most markers of systemic inflammation in all three groups of patients with pathological insulin resistance exceeded those in the control group. The most intense variations were observed with the indices of systemic inflammatory response (CRP, IL-6, IL-8 and TNFα) and microthrombosis (D-dimer). Their production elevated already at the pre-diabetes stage and increased as glycemic disturbances progressed. The increased PCT serum concentration in DM2 is presumably due to translocation of bacterial antigens from the intestine as a result of enterocyte damage. Cortisol levels in the majority of patients remained within reference values and did not differ significantly depending on the stage of insulin resistance. The same trend was observed for systemic alteration markers - myoglobin and troponin I, which can be considered as a good prognostic sign. Conclusion. In response to metabolic changes already at the early stages of hyperglycemia there is a systemic activation of proinflammatory mechanisms, which progresses with increasing signs of insulin resistance.
About the authors
Yulia Zhuravleva
Institute of Immunology and Physiology of UB RAS, Yekaterinburg, Russian Federation
Email: jazhur@mail.ru
ORCID iD: 0000-0003-3266-0954
SPIN-code: 1408-5218
Scopus Author ID: 57216158631
ResearcherId: AAK-5463-2021
PhD, senior research associate, laboratory of inflammation immunology
Russian Federation, 620078,Russia, Ekaterinburg, Pervomayskaya str., 106Yulia Turyanskaya
Ural State Medical University Yekaterinburg, Russian Federation
Email: tiger2003r@mail.ru
SPIN-code: 2745-8710
PhD, department assistant of the Hospital therapy department
Russian Federation, 620028, Russia, Ekaterinburg, Repina str., 3Lyudmila Sokolova
Ural State Medical University Yekaterinburg, Russian Federation
Email: lasokolova48@mail.ru
ORCID iD: 0000-0002-5931-9417
SPIN-code: 6461-3694
Scopus Author ID: 57196403406
ResearcherId: E-2555-2018
MD, professor, professor of the Hospital therapy department
Russian Federation, 620028, Russia, Ekaterinburg, Repina str., 3Eugeny Gusev
Institute of Immunology and Physiology of UB RAS, Yekaterinburg, Russian Federation
Author for correspondence.
Email: gusev36@mail.ru
ORCID iD: 0000-0002-7145-2376
SPIN-code: 3296-6597
Scopus Author ID: 7102224286
ResearcherId: AAE-1536-2021
MD, professor, Chief of the laboratory of inflammation immunology
Russian Federation, 620078,Russia, Ekaterinburg, Pervomayskaya str., 106References
- Гусев Е.Ю. С-реактивный белок: патогенетическое и диагностическое значение // Уральский медицинский журнал. - 2014. - Т.1 (115). - С. 113-121. Gusev E.Yu.
- C-reactive protein: pathogenetic and diagnostic value Ural medical journal? 2014, Vol. 1, no. 115, pp. 113–121.
- Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Сазонова Д.В., Мокрышева Н.Г. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. // Сахарный диабет. - 2023. - Т. 26, №2. - С. 104-123. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V, Isakov M.A., Sazonova D.V., Mokrysheva N.G. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes mellitus, 2023, Vol. 26, no. 2, pp. 104-123. doi: 10.14341/DM13035
- Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermúdez-Humarán L.G., Smirnova N., Bergé M., Sulpice T., Lahtinen S., Ouwehand A., Langella P., Rautonen N., Sansonetti P.J., Burcelin R. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med., 2011, Vol. 3(9), pp 559-72. - doi: 10.1002/emmm.201100159.
- Chiodini I., Adda G., Scillitani A., Coletti F., Morelli V., Di Lembo S., Epaminonda P., Masserini B., Beck-Peccoz P., Orsi E., Ambrosi B., Arosio M. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care, 2007, Vol. 30, no. 1, pp. 83-88. - doi: 10.2337/dc06-1267
- Gusev E., Sarapultsev A. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. Int. J. Mol. Sci., 2023, Vol. 24, no. 9, 7910. - doi: 10.3390/ijms24097910
- Hamers L., Kox M., Pickkers P. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options. Minerva Anestesiol., 2015, Vol. 81, pp. 426–439 - -
- Janssen JAMJL. New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome. Int. J. Mol. Sci., 2022, Vol. 2, no.15, 8178. - doi: 10.3390/ijms23158178
- Lucas R., Parikh S.J., Sridhar S., Guo D.H., Bhagatwala J., Dong Y., Caldwell R., Mellor A., Caldwell W., Zhu H., Dong Y. Cytokine profiling of young overweight and obese female African American adults with prediabetes. Cytokine, 2013, Vol. 64, no. 1, pp. 310-315. - doi: 10.1016/j.cyto.2013.05.025
- Mastrogiacomo L., Ballagh R., Venegas-Pino D.E., Kaur H., Shi P., Werstuck G.H. The Effects of Hyperglycemia on Early Endothelial Activation and the Initiation of Atherosclerosis. Am. J. Pathol., 2023, Vol. 193, no. 1, pp. 121-133. - doi: 10.1016/j.ajpath.2022.09.004
- Megawati E.R., Meutia N., Lubis L.D. The effect of hyperglycaemia on the macrophages in the cell culture. Folia Morphol. (Warsz)., 2022, Vol. 81, no. 2, pp. 387-393. - doi: 10.5603/FM.a2021.0017.
- Suryavanshi S.V., Kulkarni Y.A. NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes. Front. Pharmacol., 2017, Vol. 7, 798. - doi: 10.3389/fphar.2017.00798.
- Taylor R., Jones A., Kelly S., Simpson M., Mabey J. A Review of the Value of Procalcitonin as a Marker of Infection. Cureus, 2017, Vol. 9, no. 4, e1148. - doi: 10.7759/cureus.1148
- Zhang X., Deng X., Zhou J., Qiu K., Deng M., Lin Z., Mosha S.S., Li W. The Association Of Serum Cortisol Level With Microalbuminuria In Patients With Type 2 Diabetes And Prediabetes. Int. J. Med. Sci., 2020, Vol. 17, no. 18, pp. 2998-3004. - doi: 10.7150/ijms.48742
- Zotova N., Zhuravleva Y., Chereshnev V., Gusev E. Acute and Chronic Systemic Inflammation: Features and Differences in the Pathogenesis, and Integral Criteria for Verification and Differentiation. Int. J. Mol. Sci., 2023, Vol. 24, no. 2, 1144. - doi: 10.3390/ijms24021144
Supplementary files
